NCT07565805 Bern Intracoronary Optical Coherence Tomography and Coronary Computed Tomography Angiography Registry
| NCT ID | NCT07565805 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Insel Gruppe AG, University Hospital Bern |
| Condition | Coronary Artery Disease (CAD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 816 participants |
| Start Date | 2025-10-17 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 816 participants in total. It began in 2025-10-17 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Bern Intracoronary Optical Coherence Tomography and Coronary Computed Tomography Angiography Registry (BIOCORE) is a systematic institutional registry on patients undergoing paired CCTA and OCT for validation and development of advanced methods to determine coronary plaque morphology, lesion severity, PCI guidance, and it association with long-term clinical outcomes.
Eligibility Criteria
Inclusion Criteria: 1. ≥18 years of age 2. Written informed consent 3. CCTA within 3 months from invasive coronary angiography and OCT 4. At least one vessel with ≥50% diameter stenosis on CCTA 5. OCT performed in native coronary arteries (i.e. pre-PCI or no PCI) Exclusion Criteria: 1. CCTA performed more than 3 months from OCT 2. Poor OCT quality 3. Poor CCTA quality 4. Coronary anomalies 5. Prior PCI or CABG in the vessel imaged with OCT
Contact & Investigator
Lorenz Räber, Prof. MD-PhD
STUDY CHAIR
Department of Cardiology, Bern University Hospital Inselspital, Switzerland
Frequently Asked Questions
Who can join the NCT07565805 clinical trial?
This trial is open to participants of all sexes, studying Coronary Artery Disease (CAD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07565805 currently recruiting?
Yes, NCT07565805 is actively recruiting participants. Contact the research team at sarah.baer@insel.ch for enrollment information.
Where is the NCT07565805 trial being conducted?
This trial is being conducted at Bern, Switzerland.
Who is sponsoring the NCT07565805 clinical trial?
NCT07565805 is sponsored by Insel Gruppe AG, University Hospital Bern. The principal investigator is Lorenz Räber, Prof. MD-PhD at Department of Cardiology, Bern University Hospital Inselspital, Switzerland. The trial plans to enroll 816 participants.